Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,270 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

A Study of LY2584702 in Solid Tumors

NCT01241461

Conditions
Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
View Trial Details
Completed

α-TEA in Advanced Cancer

NCT02192346

Conditions
Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations
  • Providence Oncology & Hematology Care Clinic- Southeast Clackamas, Oregon, United States
  • Providence Oncology & Hematoloty Care Clinic- Newberg Newberg, Oregon, United States
  • Providence Oncology & Hematology Care Clinic- Willamette Falls Oregon City, Oregon, United States
  • Providence Oncology & Hematology Care Clinic- Eastside Portland, Oregon, United States
View Trial Details
Completed

S0916, MLN1202 in Treating Patients With Bone Metastases

NCT01015560

Conditions
Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • Glendale Memorial Hospital Comprehensive Cancer Center Glendale, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States
  • St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States
View all 47 locations
View Trial Details
Completed

Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer

NCT00777101

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +9 more
Locations
  • Arizona Oncology Associates HOPE Tucson, Arizona, United States
  • Southwest Cancer Care Murrieta, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Aptium Oncology/Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States
View all 152 locations
View Trial Details
Completed

A Study of LY3007113 in Participants With Advanced Cancer

NCT01463631

Conditions
Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Monica, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States
View Trial Details
Completed

A Study for Participants With Advanced Cancer

NCT01214629

Conditions
Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albuquerque, New Mexico, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

NCT00992225

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States
View Trial Details

Related conditions